Construction of recombinant sox2-encoding plasmids that regulate pluripotency of breast cancer stem cells from indonesian patient
A therapy development with recombinant protein is a new and potential innovation to destroy cancer stem cells (CSCs). Various ways of killing CSCs include the provision of polyvalent anti-protein antibodies that code pluripotency. Therefore, it takes a mixture of Oct-4, c-Myc, Sox2, and Klf4 protein...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Ahmad Dahlan
2019-05-01
|
Series: | Pharmaciana |
Subjects: | |
Online Access: | http://journal.uad.ac.id/index.php/PHARMACIANA/article/view/11919/pdf_116 |